1型糖尿病中的β细胞:质量与功能;休眠还是死亡?
本文综述了供者胰腺组织学分析和临床队列血清C肽测定证据,挑战了1型糖尿病中β细胞最终全部被破坏的观点。文章讨论了残余β细胞逃避免疫破坏的机制、休眠或功能障碍β细胞能否 rejuvenated 以及新β细胞生长的潜力,并指出长期糖尿病中缺乏功能恢复数据。
要点
- 组织学与C肽证据显示1型糖尿病部分患者存在残余β细胞。
- 区分β细胞质量与功能的方法存在局限。
- 长病程1型糖尿病中支持β细胞功能恢复的数据缺乏。
核心结论
- 1型糖尿病中并非所有β细胞最终都被破坏,部分患者存在残余β细胞。
- 长期糖尿病中缺乏支持β细胞功能恢复的数据。
研究设计与样本
- 综述,结合供者胰腺组织学分析与临床队列血清C肽测定证据。
主要发现
- 组织学与C肽证据挑战了1型糖尿病中β细胞全部被破坏的观点。
- 人类诊断后多年新β细胞生长的证据有限,即使存在也可能非常微小。
- 近期发病1型糖尿病中有β细胞功能恢复而非质量恢复的证据。
临床怎么用
- 应关注1型糖尿病部分患者残余β细胞的存在,而非一概认为β细胞全部死亡。
局限性
- 当前方法难以区分β细胞质量与功能。
- 长期糖尿病中β细胞功能恢复的数据缺乏。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Histological analysis of donor pancreases coupled with measurement of serum C-peptide in clinical cohorts has challenged the idea that all beta cells are eventually destroyed in type 1 diabetes. These findings have raised a number of questions regarding how the remaining beta cells have escaped immune destruction, whether pools of 'sleeping' or dysfunctional beta cells could be rejuvenated and whether there is potential for new growth of beta cells. In this Review, we describe histological and in vivo evidence of persistent beta cells in type 1 diabetes and discuss the limitations of current methods to distinguish underlying beta cell mass in comparison with beta cell function. We highlight that evidence for new beta cell growth in humans many years from diagnosis is limited, and that this growth may be very minimal if at all present. We review recent contributions to the debate around beta cell abnormalities contributing to the pathogenesis of type 1 diabetes. We also discuss evidence for restoration of beta cell function, as opposed to mass, in recent-onset type 1 diabetes, but highlight the absence of data supporting functional recovery in the setting of long-duration diabetes. Finally, future areas of research are suggested to help resolve the source and phenotype of residual beta cells that persist in some, but not all, people with type 1 diabetes.
引用
- Oram RA, Sims EK, Evans-Molina C, et al. Beta cells in type 1 diabetes: mass and function; sleeping or dead? Diabetologia. 2019. PMID: 30767048. doi:10.1007/s00125-019-4822-4
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。